Webinar: Gut Check: Scoping out Patents and the Microbiome

The microbiome is an area of biotechnology and medicine experiencing rapid growth in terms of both scientific discovery and investment activity.

Nixon Peabody, in partnership with The Microbiome Coalition and ICOSA, invites you to join us for a webinar on Tuesday, November 7, as we discuss intellectual property as it relates to the microbiome, from U.S. and European perspectives.

Aspects that will be addressed include:

• Challenges inherent to intellectual property in microbiome-related technologies, including patent-eligible subject matter, definiteness, and satisfying the disclosure requirements in a manner that supports commercially valuable patent claims
• We will examine successful strategies being employed to overcome these challenges and secure meaningful protection in this rapidly expanding arena.

Our Speakers

• Caroline de Mareüil-Villette, Partner, ICOSA
• Mark FitzGerald, Partner, Nixon Peabody LLP
• David Resnick, Partner, Nixon Peabody LLP